 | • レポートコード：GIR-107A13973 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アルツハイマー病・パーキンソン病のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アルツハイマー病・パーキンソン病の種類別市場規模（アルツハイマー病、パーキンソン病）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アルツハイマー病・パーキンソン病の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Hoffmann-La Roche、Novartis、Pfizer、Merck、Eli Lilly、Orion Pharma、UCB、AstraZeneca、Biogen、Teva Pharmaceutical Industries、AbbVie、Vertical Pharmaceuticals、ALLERGAN、ACADIA Pharmaceuticals、Impax Laboratories、GE healthcare、VTV Therapeutics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：アルツハイマー病、パーキンソン病 ・用途別分析2016年-2026年：病院、クリニック、その他 ・アルツハイマー病・パーキンソン病の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アルツハイマー病・パーキンソン病のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アルツハイマー病・パーキンソン病のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アルツハイマー病・パーキンソン病の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アルツハイマー病・パーキンソン病の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Alzheimers and Parkinsons Diseases market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Alzheimers and Parkinsons Diseases size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Alzheimers and Parkinsons Diseases market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Alzheimers and Parkinsons Diseases market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Alzheimers
Parkinsons
Market segment by Application, can be divided into
Hospital
Clinic
Other
Market segment by players, this report covers
Hoffmann-La Roche
Novartis
Pfizer
Merck
Eli Lilly
Orion Pharma
UCB
AstraZeneca
Biogen
Teva Pharmaceutical Industries
AbbVie
Vertical Pharmaceuticals
ALLERGAN
ACADIA Pharmaceuticals
Impax Laboratories
GE healthcare
VTV Therapeutics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Alzheimers and Parkinsons Diseases
1.2 Classification of Alzheimers and Parkinsons Diseases by Type
1.2.1 Overview: Global Alzheimers and Parkinsons Diseases Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Alzheimers and Parkinsons Diseases Revenue Market Share by Type in 2020
1.2.3 Alzheimers
1.2.4 Parkinsons
1.3 Global Alzheimers and Parkinsons Diseases Market by Application
1.3.1 Overview: Global Alzheimers and Parkinsons Diseases Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Alzheimers and Parkinsons Diseases Market Size & Forecast
1.5 Global Alzheimers and Parkinsons Diseases Market Size and Forecast by Region
1.5.1 Global Alzheimers and Parkinsons Diseases Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Alzheimers and Parkinsons Diseases Market Size by Region, (2016-2021)
1.5.3 North America Alzheimers and Parkinsons Diseases Market Size and Prospect (2016-2026)
1.5.4 Europe Alzheimers and Parkinsons Diseases Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Alzheimers and Parkinsons Diseases Market Size and Prospect (2016-2026)
1.5.6 South America Alzheimers and Parkinsons Diseases Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Alzheimers and Parkinsons Diseases Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Alzheimers and Parkinsons Diseases Market Drivers
1.6.2 Alzheimers and Parkinsons Diseases Market Restraints
1.6.3 Alzheimers and Parkinsons Diseases Trends Analysis
2 Company Profiles
2.1 Hoffmann-La Roche
2.1.1 Hoffmann-La Roche Details
2.1.2 Hoffmann-La Roche Major Business
2.1.3 Hoffmann-La Roche Alzheimers and Parkinsons Diseases Product and Solutions
2.1.4 Hoffmann-La Roche Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Hoffmann-La Roche Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Alzheimers and Parkinsons Diseases Product and Solutions
2.2.4 Novartis Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Alzheimers and Parkinsons Diseases Product and Solutions
2.3.4 Pfizer Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Pfizer Recent Developments and Future Plans
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business
2.4.3 Merck Alzheimers and Parkinsons Diseases Product and Solutions
2.4.4 Merck Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Merck Recent Developments and Future Plans
2.5 Eli Lilly
2.5.1 Eli Lilly Details
2.5.2 Eli Lilly Major Business
2.5.3 Eli Lilly Alzheimers and Parkinsons Diseases Product and Solutions
2.5.4 Eli Lilly Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Eli Lilly Recent Developments and Future Plans
2.6 Orion Pharma
2.6.1 Orion Pharma Details
2.6.2 Orion Pharma Major Business
2.6.3 Orion Pharma Alzheimers and Parkinsons Diseases Product and Solutions
2.6.4 Orion Pharma Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Orion Pharma Recent Developments and Future Plans
2.7 UCB
2.7.1 UCB Details
2.7.2 UCB Major Business
2.7.3 UCB Alzheimers and Parkinsons Diseases Product and Solutions
2.7.4 UCB Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 UCB Recent Developments and Future Plans
2.8 AstraZeneca
2.8.1 AstraZeneca Details
2.8.2 AstraZeneca Major Business
2.8.3 AstraZeneca Alzheimers and Parkinsons Diseases Product and Solutions
2.8.4 AstraZeneca Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 AstraZeneca Recent Developments and Future Plans
2.9 Biogen
2.9.1 Biogen Details
2.9.2 Biogen Major Business
2.9.3 Biogen Alzheimers and Parkinsons Diseases Product and Solutions
2.9.4 Biogen Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Biogen Recent Developments and Future Plans
2.10 Teva Pharmaceutical Industries
2.10.1 Teva Pharmaceutical Industries Details
2.10.2 Teva Pharmaceutical Industries Major Business
2.10.3 Teva Pharmaceutical Industries Alzheimers and Parkinsons Diseases Product and Solutions
2.10.4 Teva Pharmaceutical Industries Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Teva Pharmaceutical Industries Recent Developments and Future Plans
2.11 AbbVie
2.11.1 AbbVie Details
2.11.2 AbbVie Major Business
2.11.3 AbbVie Alzheimers and Parkinsons Diseases Product and Solutions
2.11.4 AbbVie Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 AbbVie Recent Developments and Future Plans
2.12 Vertical Pharmaceuticals
2.12.1 Vertical Pharmaceuticals Details
2.12.2 Vertical Pharmaceuticals Major Business
2.12.3 Vertical Pharmaceuticals Alzheimers and Parkinsons Diseases Product and Solutions
2.12.4 Vertical Pharmaceuticals Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Vertical Pharmaceuticals Recent Developments and Future Plans
2.13 ALLERGAN
2.13.1 ALLERGAN Details
2.13.2 ALLERGAN Major Business
2.13.3 ALLERGAN Alzheimers and Parkinsons Diseases Product and Solutions
2.13.4 ALLERGAN Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 ALLERGAN Recent Developments and Future Plans
2.14 ACADIA Pharmaceuticals
2.14.1 ACADIA Pharmaceuticals Details
2.14.2 ACADIA Pharmaceuticals Major Business
2.14.3 ACADIA Pharmaceuticals Alzheimers and Parkinsons Diseases Product and Solutions
2.14.4 ACADIA Pharmaceuticals Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 ACADIA Pharmaceuticals Recent Developments and Future Plans
2.15 Impax Laboratories
2.15.1 Impax Laboratories Details
2.15.2 Impax Laboratories Major Business
2.15.3 Impax Laboratories Alzheimers and Parkinsons Diseases Product and Solutions
2.15.4 Impax Laboratories Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Impax Laboratories Recent Developments and Future Plans
2.16 GE healthcare
2.16.1 GE healthcare Details
2.16.2 GE healthcare Major Business
2.16.3 GE healthcare Alzheimers and Parkinsons Diseases Product and Solutions
2.16.4 GE healthcare Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 GE healthcare Recent Developments and Future Plans
2.17 VTV Therapeutics
2.17.1 VTV Therapeutics Details
2.17.2 VTV Therapeutics Major Business
2.17.3 VTV Therapeutics Alzheimers and Parkinsons Diseases Product and Solutions
2.17.4 VTV Therapeutics Alzheimers and Parkinsons Diseases Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 VTV Therapeutics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Alzheimers and Parkinsons Diseases Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Alzheimers and Parkinsons Diseases Players Market Share
3.2.2 Top 10 Alzheimers and Parkinsons Diseases Players Market Share
3.2.3 Market Competition Trend
3.3 Alzheimers and Parkinsons Diseases Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Alzheimers and Parkinsons Diseases Revenue and Market Share by Type (2016-2021)
4.2 Global Alzheimers and Parkinsons Diseases Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Alzheimers and Parkinsons Diseases Revenue Market Share by Application (2016-2021)
5.2 Alzheimers and Parkinsons Diseases Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Alzheimers and Parkinsons Diseases Revenue by Type (2016-2026)
6.2 North America Alzheimers and Parkinsons Diseases Revenue by Application (2016-2026)
6.3 North America Alzheimers and Parkinsons Diseases Market Size by Country
6.3.1 North America Alzheimers and Parkinsons Diseases Revenue by Country (2016-2026)
6.3.2 United States Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
6.3.3 Canada Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
6.3.4 Mexico Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Alzheimers and Parkinsons Diseases Revenue by Type (2016-2026)
7.2 Europe Alzheimers and Parkinsons Diseases Revenue by Application (2016-2026)
7.3 Europe Alzheimers and Parkinsons Diseases Market Size by Country
7.3.1 Europe Alzheimers and Parkinsons Diseases Revenue by Country (2016-2026)
7.3.2 Germany Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
7.3.3 France Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
7.3.5 Russia Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
7.3.6 Italy Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Alzheimers and Parkinsons Diseases Revenue by Type (2016-2026)
8.2 Asia-Pacific Alzheimers and Parkinsons Diseases Revenue by Application (2016-2026)
8.3 Asia-Pacific Alzheimers and Parkinsons Diseases Market Size by Region
8.3.1 Asia-Pacific Alzheimers and Parkinsons Diseases Revenue by Region (2016-2026)
8.3.2 China Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
8.3.3 Japan Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
8.3.4 South Korea Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
8.3.5 India Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
8.3.7 Australia Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Alzheimers and Parkinsons Diseases Revenue by Type (2016-2026)
9.2 South America Alzheimers and Parkinsons Diseases Revenue by Application (2016-2026)
9.3 South America Alzheimers and Parkinsons Diseases Market Size by Country
9.3.1 South America Alzheimers and Parkinsons Diseases Revenue by Country (2016-2026)
9.3.2 Brazil Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
9.3.3 Argentina Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Alzheimers and Parkinsons Diseases Revenue by Type (2016-2026)
10.2 Middle East & Africa Alzheimers and Parkinsons Diseases Revenue by Application (2016-2026)
10.3 Middle East & Africa Alzheimers and Parkinsons Diseases Market Size by Country
10.3.1 Middle East & Africa Alzheimers and Parkinsons Diseases Revenue by Country (2016-2026)
10.3.2 Turkey Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
10.3.4 UAE Alzheimers and Parkinsons Diseases Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Alzheimers and Parkinsons Diseases Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Alzheimers and Parkinsons Diseases Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Alzheimers and Parkinsons Diseases Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Alzheimers and Parkinsons Diseases Revenue (USD Million) by Region (2016-2021)
Table 5. Global Alzheimers and Parkinsons Diseases Revenue Market Share by Region (2021-2026)
Table 6. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 7. Hoffmann-La Roche Major Business
Table 8. Hoffmann-La Roche Alzheimers and Parkinsons Diseases Product and Solutions
Table 9. Hoffmann-La Roche Alzheimers and Parkinsons Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Alzheimers and Parkinsons Diseases Product and Solutions
Table 13. Novartis Alzheimers and Parkinsons Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Pfizer Corporate Information, Head Office, and Major Competitors
Table 15. Pfizer Major Business
Table 16. Pfizer Alzheimers and Parkinsons Diseases Product and Solutions
Table 17. Pfizer Alzheimers and Parkinsons Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Merck Corporate Information, Head Office, and Major Competitors
Table 19. Merck Major Business
Table 20. Merck Alzheimers and Parkinsons Diseases Product and Solutions
Table 21. Merck Alzheimers and Parkinsons Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Eli Lilly Corporate Information, Head Office, and Major Competitors
Table 23. Eli Lilly Major Business
Table 24. Eli Lilly Alzheimers and Parkinsons Diseases Product and Solutions
Table 25. Eli Lilly Alzheimers and Parkinsons Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Orion Pharma Corporate Information, Head Office, and Major Competitors
Table 27. Orion Pharma Major Business
Table 28. Orion Pharma Alzheimers and Parkinsons Diseases Product and Solutions
Table 29. Orion Pharma Alzheimers and Parkinsons Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. UCB Corporate Information, Head Office, and Major Competitors
Table 31. UCB Major Business
Table 32. UCB Alzheimers and Parkinsons Diseases Product and Solutions
Table 33. UCB Alzheimers and Parkinsons Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. AstraZeneca Corporate Information, Head Office, and Major Competitors
Table 35. AstraZeneca Major Business
Table 36. AstraZeneca Alzheimers and Parkinsons Diseases Product and Solutions
Table 37. AstraZeneca Alzheimers and Parkinsons Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Biogen Corporate Information, Head Office, and Major Competitors
Table 39. Biogen Major Business
Table 40. Biogen Alzheimers and Parkinsons Diseases Product and Solutions
Table 41. Biogen Alzheimers and Parkinsons Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Teva Pharmaceutical Industries Corporate Information, Head Office, and Major Competitors
Table 43. Teva Pharmaceutical Industries Major Business
Table 44. Teva Pharmaceutical Industries Alzheimers and Parkinsons Diseases Product and Solutions
Table 45. Teva Pharmaceutical Industries Alzheimers and Parkinsons Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. AbbVie Corporate Information, Head Office, and Major Competitors
Table 47. AbbVie Major Business
Table 48. AbbVie Alzheimers and Parkinsons Diseases Product and Solutions
Table 49. AbbVie Alzheimers and Parkinsons Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Vertical Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 51. Vertical Pharmaceuticals Major Business
Table 52. Vertical Pharmaceuticals Alzheimers and Parkinsons Diseases Product and Solutions
Table 53. Vertical Pharmaceuticals Alzheimers and Parkinsons Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. ALLERGAN Corporate Information, Head Office, and Major Competitors
Table 55. ALLERGAN Major Business
Table 56. ALLERGAN Alzheimers and Parkinsons Diseases Product and Solutions
Table 57. ALLERGAN Alzheimers and Parkinsons Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. ACADIA Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 59. ACADIA Pharmaceuticals Major Business
Table 60. ACADIA Pharmaceuticals Alzheimers and Parkinsons Diseases Product and Solutions
Table 61. ACADIA Pharmaceuticals Alzheimers and Parkinsons Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Impax Laboratories Corporate Information, Head Office, and Major Competitors
Table 63. Impax Laboratories Major Business
Table 64. Impax Laboratories Alzheimers and Parkinsons Diseases Product and Solutions
Table 65. Impax Laboratories Alzheimers and Parkinsons Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. GE healthcare Corporate Information, Head Office, and Major Competitors
Table 67. GE healthcare Major Business
Table 68. GE healthcare Alzheimers and Parkinsons Diseases Product and Solutions
Table 69. GE healthcare Alzheimers and Parkinsons Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. VTV Therapeutics Corporate Information, Head Office, and Major Competitors
Table 71. VTV Therapeutics Major Business
Table 72. VTV Therapeutics Alzheimers and Parkinsons Diseases Product and Solutions
Table 73. VTV Therapeutics Alzheimers and Parkinsons Diseases Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. Global Alzheimers and Parkinsons Diseases Revenue (USD Million) by Players (2019-2021)
Table 75. Global Alzheimers and Parkinsons Diseases Revenue Share by Players (2019-2021)
Table 76. Breakdown of Alzheimers and Parkinsons Diseases by Company Type (Tier 1, Tier 2 and Tier 3)
Table 77. Alzheimers and Parkinsons Diseases Players Head Office, Products and Services Provided
Table 78. Alzheimers and Parkinsons Diseases Mergers & Acquisitions in the Past Five Years
Table 79. Alzheimers and Parkinsons Diseases New Entrants and Expansion Plans
Table 80. Global Alzheimers and Parkinsons Diseases Revenue (USD Million) by Type (2016-2021)
Table 81. Global Alzheimers and Parkinsons Diseases Revenue Share by Type (2016-2021)
Table 82. Global Alzheimers and Parkinsons Diseases Revenue Forecast by Type (2021-2026)
Table 83. Global Alzheimers and Parkinsons Diseases Revenue by Application (2016-2021)
Table 84. Global Alzheimers and Parkinsons Diseases Revenue Forecast by Application (2021-2026)
Table 85. North America Alzheimers and Parkinsons Diseases Revenue by Type (2016-2021) & (USD Million)
Table 86. North America Alzheimers and Parkinsons Diseases Revenue by Type (2021-2026) & (USD Million)
Table 87. North America Alzheimers and Parkinsons Diseases Revenue by Application (2016-2021) & (USD Million)
Table 88. North America Alzheimers and Parkinsons Diseases Revenue by Application (2021-2026) & (USD Million)
Table 89. North America Alzheimers and Parkinsons Diseases Revenue by Country (2016-2021) & (USD Million)
Table 90. North America Alzheimers and Parkinsons Diseases Revenue by Country (2021-2026) & (USD Million)
Table 91. Europe Alzheimers and Parkinsons Diseases Revenue by Type (2016-2021) & (USD Million)
Table 92. Europe Alzheimers and Parkinsons Diseases Revenue by Type (2021-2026) & (USD Million)
Table 93. Europe Alzheimers and Parkinsons Diseases Revenue by Application (2016-2021) & (USD Million)
Table 94. Europe Alzheimers and Parkinsons Diseases Revenue by Application (2021-2026) & (USD Million)
Table 95. Europe Alzheimers and Parkinsons Diseases Revenue by Country (2016-2021) & (USD Million)
Table 96. Europe Alzheimers and Parkinsons Diseases Revenue by Country (2021-2026) & (USD Million)
Table 97. Asia-Pacific Alzheimers and Parkinsons Diseases Revenue by Type (2016-2021) & (USD Million)
Table 98. Asia-Pacific Alzheimers and Parkinsons Diseases Revenue by Type (2021-2026) & (USD Million)
Table 99. Asia-Pacific Alzheimers and Parkinsons Diseases Revenue by Application (2016-2021) & (USD Million)
Table 100. Asia-Pacific Alzheimers and Parkinsons Diseases Revenue by Application (2021-2026) & (USD Million)
Table 101. Asia-Pacific Alzheimers and Parkinsons Diseases Revenue by Region (2016-2021) & (USD Million)
Table 102. Asia-Pacific Alzheimers and Parkinsons Diseases Revenue by Region (2021-2026) & (USD Million)
Table 103. South America Alzheimers and Parkinsons Diseases Revenue by Type (2016-2021) & (USD Million)
Table 104. South America Alzheimers and Parkinsons Diseases Revenue by Type (2021-2026) & (USD Million)
Table 105. South America Alzheimers and Parkinsons Diseases Revenue by Application (2016-2021) & (USD Million)
Table 106. South America Alzheimers and Parkinsons Diseases Revenue by Application (2021-2026) & (USD Million)
Table 107. South America Alzheimers and Parkinsons Diseases Revenue by Country (2016-2021) & (USD Million)
Table 108. South America Alzheimers and Parkinsons Diseases Revenue by Country (2021-2026) & (USD Million)
Table 109. Middle East & Africa Alzheimers and Parkinsons Diseases Revenue by Type (2016-2021) & (USD Million)
Table 110. Middle East & Africa Alzheimers and Parkinsons Diseases Revenue by Type (2021-2026) & (USD Million)
Table 111. Middle East & Africa Alzheimers and Parkinsons Diseases Revenue by Application (2016-2021) & (USD Million)
Table 112. Middle East & Africa Alzheimers and Parkinsons Diseases Revenue by Application (2021-2026) & (USD Million)
Table 113. Middle East & Africa Alzheimers and Parkinsons Diseases Revenue by Country (2016-2021) & (USD Million)
Table 114. Middle East & Africa Alzheimers and Parkinsons Diseases Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Alzheimers and Parkinsons Diseases Picture
Figure 2. Global Alzheimers and Parkinsons Diseases Revenue Market Share by Type in 2020
Figure 3. Alzheimers
Figure 4. Parkinsons
Figure 5. Alzheimers and Parkinsons Diseases Revenue Market Share by Application in 2020
Figure 6. Hospital Picture
Figure 7. Clinic Picture
Figure 8. Other Picture
Figure 9. Global Alzheimers and Parkinsons Diseases Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Alzheimers and Parkinsons Diseases Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Alzheimers and Parkinsons Diseases Revenue Market Share by Region (2016-2026)
Figure 12. Global Alzheimers and Parkinsons Diseases Revenue Market Share by Region in 2020
Figure 13. North America Alzheimers and Parkinsons Diseases Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Alzheimers and Parkinsons Diseases Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Alzheimers and Parkinsons Diseases Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Alzheimers and Parkinsons Diseases Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Middle East and Africa Alzheimers and Parkinsons Diseases Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Alzheimers and Parkinsons Diseases Market Drivers
Figure 19. Alzheimers and Parkinsons Diseases Market Restraints
Figure 20. Alzheimers and Parkinsons Diseases Market Trends
Figure 21. Hoffmann-La Roche Recent Developments and Future Plans
Figure 22. Novartis Recent Developments and Future Plans
Figure 23. Pfizer Recent Developments and Future Plans
Figure 24. Merck Recent Developments and Future Plans
Figure 25. Eli Lilly Recent Developments and Future Plans
Figure 26. Orion Pharma Recent Developments and Future Plans
Figure 27. UCB Recent Developments and Future Plans
Figure 28. AstraZeneca Recent Developments and Future Plans
Figure 29. Biogen Recent Developments and Future Plans
Figure 30. Teva Pharmaceutical Industries Recent Developments and Future Plans
Figure 31. AbbVie Recent Developments and Future Plans
Figure 32. Vertical Pharmaceuticals Recent Developments and Future Plans
Figure 33. ALLERGAN Recent Developments and Future Plans
Figure 34. ACADIA Pharmaceuticals Recent Developments and Future Plans
Figure 35. Impax Laboratories Recent Developments and Future Plans
Figure 36. GE healthcare Recent Developments and Future Plans
Figure 37. VTV Therapeutics Recent Developments and Future Plans
Figure 38. Global Alzheimers and Parkinsons Diseases Revenue Share by Players in 2020
Figure 39. Alzheimers and Parkinsons Diseases Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 40. Global Top 3 Players Alzheimers and Parkinsons Diseases Revenue Market Share in 2020
Figure 41. Global Top 10 Players Alzheimers and Parkinsons Diseases Revenue Market Share in 2020
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 43. Global Alzheimers and Parkinsons Diseases Revenue Share by Type in 2020
Figure 44. Global Alzheimers and Parkinsons Diseases Market Share Forecast by Type (2021-2026)
Figure 45. Global Alzheimers and Parkinsons Diseases Revenue Share by Application in 2020
Figure 46. Global Alzheimers and Parkinsons Diseases Market Share Forecast by Application (2021-2026)
Figure 47. North America Alzheimers and Parkinsons Diseases Sales Market Share by Type (2016-2026)
Figure 48. North America Alzheimers and Parkinsons Diseases Sales Market Share by Application (2016-2026)
Figure 49. North America Alzheimers and Parkinsons Diseases Revenue Market Share by Country (2016-2026)
Figure 50. United States Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Canada Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Mexico Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Europe Alzheimers and Parkinsons Diseases Sales Market Share by Type (2016-2026)
Figure 54. Europe Alzheimers and Parkinsons Diseases Sales Market Share by Application (2016-2026)
Figure 55. Europe Alzheimers and Parkinsons Diseases Revenue Market Share by Country (2016-2026)
Figure 56. Germany Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. France Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. United Kingdom Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Russia Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Italy Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Asia-Pacific Alzheimers and Parkinsons Diseases Sales Market Share by Type (2016-2026)
Figure 62. Asia-Pacific Alzheimers and Parkinsons Diseases Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Alzheimers and Parkinsons Diseases Revenue Market Share by Region (2016-2026)
Figure 64. China Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Japan Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South Korea Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. India Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Southeast Asia Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Australia Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. South America Alzheimers and Parkinsons Diseases Sales Market Share by Type (2016-2026)
Figure 71. South America Alzheimers and Parkinsons Diseases Sales Market Share by Application (2016-2026)
Figure 72. South America Alzheimers and Parkinsons Diseases Revenue Market Share by Country (2016-2026)
Figure 73. Brazil Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Argentina Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Middle East and Africa Alzheimers and Parkinsons Diseases Sales Market Share by Type (2016-2026)
Figure 76. Middle East and Africa Alzheimers and Parkinsons Diseases Sales Market Share by Application (2016-2026)
Figure 77. Middle East and Africa Alzheimers and Parkinsons Diseases Revenue Market Share by Country (2016-2026)
Figure 78. Turkey Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Saudi Arabia Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. UAE Alzheimers and Parkinsons Diseases Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界のパーキンソン病治療薬市場 2021：企業別、地域別、種類・用途別 The Parkinsons Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…- 世界の寄生虫症治療市場 2021：企業別、地域別、種類・用途別 The Parasitic Diseases Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の運動ニューロン疾患治療市場 2021：企業別、地域別、種類・用途別 The Motor Neuron Diseases Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界の性感染症（STD）治療市場 2021：企業別、地域別、種類・用途別 The Sexually Transmitted Diseases (STD) Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 世界の顧みられない熱帯病診断市場 2021：企業別、地域別、種類・用途別 The Neglected Tropical Diseases Diagnosis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…